Results 111 to 120 of about 3,507,689 (226)
The in vivo regulation of coagulation is mainly controlled by plasma inhibitors in which antithrombin III (AT III) plays an importance role. AT III is a glycoprotein which inhibits all serine proteases, except factor, VIIa, generated during the coagulation process. The proteases are inactivated by formation of an equimolecular complex and this reaction
C, Boyer-Neumann, M, Wolf, M J, Larrieu
openaire +3 more sources
This study is a comprehensive post‐market analysis of the Xenios console and XLung kit 230 preconfigured ECMO tubing set in post‐cardiotomy applications. The performance of this device was evaluated and demonstrated in all key clinical areas, with an adequate safety profile.
Luca Conci +9 more
wiley +1 more source
The Role of Thalassaemic Red Cells in the Mechanism Process of Hypercoagulable State in Thalassaemia
Background: Thromboembolic events (TEEs) are recognized complications in thalassaemia, arising from a hypercoagulable state driven by multiple proposed mechanisms.
Wardah Roslan +11 more
doaj +1 more source
Antithrombin-III and platelets in hemodialysis patients
Plasma antithrombin-III (AT-III) levels in 18 patients on maintenance hemodialysis were studied. AT-III was measured functionally and immunologically before and after dialysis. Simultaneous counts of platelets were made.
Sorensen, L. H. +2 more
core +1 more source
BACKGROUND AND OBJECTIVES: Hepatic veno-occlusive disease (VOD) remains a serious complication after hematopoietic stem cell transplantation (HSCT). Based on a protective effect of antithrombin III (ATIII) on endothelial cells, we assessed the incidence ...
U Haussmann +5 more
doaj
Antithrombin III inhibits thrombin-induced proliferation in human arterial smooth muscle cells.
Thrombin has attracted increasing attention as a possible mitogen for vascular smooth muscle cells in lesion development both after vascular injury and in atherogenesis. In this study, the ability of antithrombin III to inhibit alpha-thrombin-induced DNA
J Sanchez +4 more
core +1 more source
Plasma antithrombin III activity was studied in 22 patients with prostatic cancer who were on estrogen therapy. Normal plasma antithrombin III activity varies between 0.80 and 1.40 U. per ml. A loading dose of 15 mg.
Dabhoiwala, N. F. +4 more
core
This study was carried out to determine whether the administration of antithrombin III decreases the risk of intraventricular hemorrhage in premature infants.
GITTO, Eloisa +7 more
core +1 more source
Prognostic Value of Anti-Thrombin III Level in Neonatal Sepsis
Background: To determine levels of Antithrombin III and its prognostic value in predicting neonatal sepsis. Methods: In this descriptive study full term neonates (n=70)were recruited.
Sidra Tul Muntaha
doaj
Background The assessment of level severity in patient with community acquired pneumonia (CAP) is very important to determine the next management of disease.
Andriyani, Sari
core +3 more sources

